We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
featured

Journal Scan / Research · June 16, 2021

Anticoagulation Treatment in COVID-19 Patients With Elevated D-Dimer

The Lancet

 

Additional Info

Disclosure statements are available on the authors' profiles:

The Lancet
Therapeutic Versus Prophylactic Anticoagulation for Patients Admitted to Hospital With COVID-19 and Elevated D-Dimer Concentration (ACTION): An Open-Label, Multicentre, Randomised, Controlled Trial
Lancet 2021 Jun 12;397(10291)2253-2263, RD Lopes, PGM de Barros E Silva, RHM Furtado, AVS Macedo, B Bronhara, LP Damiani, LM Barbosa, J de Aveiro Morata, E Ramacciotti, P de Aquino Martins, AL de Oliveira, VS Nunes, LEF Ritt, AT Rocha, L Tramujas, SV Santos, DRA Diaz, LS Viana, LMG Melro, MS de Alcântara Chaud, EL Figueiredo, FC Neuenschwander, MDA Dracoulakis, RGSD Lima, VC de Souza Dantas, ACS Fernandes, OCE Gebara, ME Hernandes, DAR Queiroz, VC Veiga, MF Canesin, LM de Faria, GS Feitosa-Filho, MB Gazzana, IL Liporace, A de Oliveira Twardowsky, LN Maia, FR Machado, A de Matos Soeiro, GE Conceição-Souza, L Armaganijan, PO Guimarães, RG Rosa, LCP Azevedo, JH Alexander, A Avezum, AB Cavalcanti, O Berwanger, ACTION Coalition COVID-19 Brazil IV Investigators

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading